IBMS Congress 2025

Dr Michelle Brereton

Chief Biomedical Scientist, Manchester University NHS Foundation Trust

Michelle is Chief Biomedical Scientist at the Haematological Cancer Diagnostic Service at Manchester Foundation Trust, working alongside clinical and laboratory based colleagues to provide morphology reporting of blood and bone marrows.

Michelle also works with UK NEQASH to deliver the Digital Morphology  Scheme for CPD and completed her Doctorate thesis based on the common types of error that occur when examining blood films. With 24 publications in peer reviewed journals Michelle remains passionate about the role Biomedical Scientists play in delivering a quality service to patients.

Dr John Burthem

Consultant Haematologist, Manchester University NHS Foundation Trust

John is Consultant Haematologist and Clinical Senior Lecturer and lead for the Haematological Cancer Diagnositics Partnership based at Manchester Hospitals. With a particular Interest in morphology he Chairs the Scientific Advisory Group for Morphology at UK NEQAS(H).

Together with Michelle Brereton, John provide images, annotations and feedback for the UK NEQAS(H) Digital Morphology Scheme and is the main author of haematologyetc.co.uk - a wiki help for morphology and other aspects of haematology diagnosis.

Professor Barbara Bain

Professor of Diagnostic Haematology, St Mary's Imperial College Healthcare NHS Trust

Professor Barbara Bain started her career in haematology, in Australia, more than 50 years ago. She now works in diagnostic haematology only but was previously involved also in clinical haematology. She has worked at: Princess Alexandra Hospital, Brisbane; Hammersmith Hospital London; and St Mary's Hospital, London. She is the author or co-author of books on blood cell morphology, bone marrow pathology, haemoglobinopathy diagnosis and leukaemia diagnosis.

Dr Hayder Hussain

University Hospitals Birmingham NHS Foundation Trust

No bio provided

Professor Barbara Bain

Professor of Diagnostic Haematology, St Mary's Imperial College Healthcare NHS Trust

Professor Barbara Bain started her career in haematology, in Australia, more than 50 years ago. She now works in diagnostic haematology only but was previously involved also in clinical haematology. She has worked at: Princess Alexandra Hospital, Brisbane; Hammersmith Hospital London; and St Mary's Hospital, London. She is the author or co-author of books on blood cell morphology, bone marrow pathology, haemoglobinopathy diagnosis and leukaemia diagnosis.

Dr Hayder Hussain

University Hospitals Birmingham NHS Foundation Trust

No bio provided

Dr Michelle Brereton

Chief Biomedical Scientist, Manchester University NHS Foundation Trust

Michelle is Chief Biomedical Scientist at the Haematological Cancer Diagnostic Service at Manchester Foundation Trust, working alongside clinical and laboratory based colleagues to provide morphology reporting of blood and bone marrows.

Michelle also works with UK NEQASH to deliver the Digital Morphology  Scheme for CPD and completed her Doctorate thesis based on the common types of error that occur when examining blood films. With 24 publications in peer reviewed journals Michelle remains passionate about the role Biomedical Scientists play in delivering a quality service to patients.

Dr John Burthem

Consultant Haematologist, Manchester University NHS Foundation Trust

John is Consultant Haematologist and Clinical Senior Lecturer and lead for the Haematological Cancer Diagnositics Partnership based at Manchester Hospitals. With a particular Interest in morphology he Chairs the Scientific Advisory Group for Morphology at UK NEQAS(H).

Together with Michelle Brereton, John provide images, annotations and feedback for the UK NEQAS(H) Digital Morphology Scheme and is the main author of haematologyetc.co.uk - a wiki help for morphology and other aspects of haematology diagnosis.

Nicola Lawrence

University Hospitals of the North Midlands NHS Trust

No bio provided

Dr Richard Buka

Birmingham Women’s and Children’s NHS Foundation Trust

No bio provided

Dr Mosavar Farahani

University of Northampton

No bio provided

Alison Brown

The Newcastle upon Tyne Hospitals NHS Foundation Trust

No bio provided

Professor Bashir Lwaleed

University of Southampton

No bio provided

Dr Rashid Kazmi

Consultant Haematologist, University Hospital Southampton NHS Foundation Trust

Dr Rashid is a Consultant Haematologist and Honorary Senior Clinical Lecturer at University of Southampton. He is the Director of Southampton Haemostasis and Thrombosis Cente with an overall clinical and administrative responsibility for bleeding and thrombotic disorder patients.

Dr Rashid has a busy research porfolio and is currently engaged in a number of clinical trials in Haemophilia, Immune Thrombocytopenia and autoimmune haemolytic anaemias exploring gene therapy, cell therapy and novel treatments.

Daniel Payne

Consultant Clinical Scientist, South Tees Hospitals NHS Foundation Trust

Daniel is a Consultant Clinical Scientist at HMDS Leeds. He is a member of MIG and DIG flow cytometry working groups, an author on international PNH guidelines and UK consensus group for PNH testing.

Alanna Masson

NHS Grampian Aberdeen Royal Infi rmary

No bio provided

Zoe Pickering

Tameside and Glossop Integrated Care NHS Foundation Trust

No bio provided

Dr Ian Jennings

UK NEQAS - Blood Coagulation

No bio provided

Dr Sukhjinder Marwah

Senior Biomedical Scientist in Haemoglobinopathy, Royal Wolverhampton NHS Trust

Dr Sukhjinder Singh Marwah, Haemoglobinopathy lead, has worked in the haematology department at SWBH Trust since 1988 and currently works for Black Country Pathology Service (BCPS). He has participated in a range of service improvement initiatives and in addition, is an Honorary Lecturer in Haemoglobinopathy at the University of Coventry and Wolverhampton.

Recently, a research study, led by Sandwell Senior Biomedical Scientist Dr Sukhjinder Marwah to identify a new prognostic biomarker(Lactate Dehydrogenase/Albumin To-Urea Ratio: A Novel Prognostic Maker for Fatal Clinical Complications in Patients with COVID-19 Infection) in COVID-19 patients, has been published in a Journal of Clinical Medicine.

Jayne Parkes

Black Country Pathology Services, The Royal Wolverhampton NHS Trust

No bio provided

Dr Barbara De La Selle

Director, UK NEQAS Haematology

Barbara is a consultant clinical scientist and Director of the UK NEQAS Haematology external quality assessment scheme.  Before joining UK NEQAS in 2001, she worked for many years in a clinical laboratory, first in general haematology and later specialising in the laboratory diagnosis of inherited red cell disorders at St Bartholomew’s and the Royal London Hospitals in Central London.  She is a member of the UK NEQAS Charity’s Board of Trustees and a Board Member of ISLH.

Graeme Bain

East Kent Hospitals University NHS Foundation Trust

No bio provided

Rev Dr Gordon Sinclair

Senior Lecturer in Biomedical Science , London Metropolitan University

Rev Dr Gordon Sinclair is a Senior Lecturer in Biomedical Science at London Metropolitan University, Chair of the Haematology National Quality Assurance Advisory Panel, Interim Chair of the Quality Assurance in Pathology, Vice-Chair of the Institute of Biomedical Science, Haematology, Scientific Advisory Panel, and Pastor of Kingdom Community Church, Redhill. He lectures in ethics, statistics, haematology and blood transfusion science, mainly at the postgraduate level. His research interests include the moon’s age and developing a cheap alternative to standard cell counting for developing nations.

Dr Fiona Clark

Consultant Haematologist, University Hospitals of North Midlands NHS Trust

No bio provided

Dr Pip Nicolson

University of Birmingham

No bio provided

Annabel Booth-Hankey

University Hospitals of North Midlands NHS Trust

No bio provided